首页> 外文期刊>Interventional cardiology. >Evaluating neoatherosclerosis for risk stratification of very-late DES failure
【24h】

Evaluating neoatherosclerosis for risk stratification of very-late DES failure

机译:评价新动脉粥样硬化对严重DES失败的风险分层

获取原文
获取原文并翻译 | 示例
           

摘要

Drug-eluting stents (DESs) in comparison with bare metal stents (BMSs) have reduced early target lesion revascularization (TLR) through exerting an inhibitory effect on smooth muscle cell hyperplasia but have also increased the risk of stent thrombosis and TLR after 1 year, in other words, very-late stent failure (VLSF). Neoatherosclerosis or atherosclerosis progression is thought to be the major mechanism and is regarded as a 'final common pathway of VLSF.' Atherosclerosis can be detected by various intracoronary imaging modalities; e.g., angioscopy detects it as yellow plaque that has been regarded as vulnerable plaque and is associated with future event of acute coronary syndrome. Here, the findings of neoatherosclerosis using intracoronary imaging are reviewed and their relation with the long-term clinical outcome is discussed.
机译:与裸金属支架(BMS)相比,药物洗脱支架(DESs)通过对平滑肌细胞增生产生抑制作用,减少了早期靶病变血运重建(TLR),但也增加了1年后支架血栓和TLR的风险,换句话说,非常晚期的支架衰竭(VLSF)。新动脉粥样硬化或动脉粥样硬化进展被认为是主要机制,被认为是“ VLSF的最终共同途径”。动脉粥样硬化可以通过各种冠状动脉内成像方式进行检测。例如,血管镜检查将其检测为黄色斑块,该黄色斑块被认为是易损斑块,并与急性冠状动脉综合征的未来事件相关。在这里,回顾了使用冠状动脉内成像的新动脉粥样硬化的发现,并讨论了它们与长期临床结果的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号